2F7 Stock Overview
John Wiley & Sons, Inc. operates as a research and education company worldwide.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 4/6 |
John Wiley & Sons, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$33.80 |
52 Week High | US$37.00 |
52 Week Low | US$27.00 |
Beta | 0.88 |
1 Month Change | 9.03% |
3 Month Change | 15.75% |
1 Year Change | -2.87% |
3 Year Change | -23.87% |
5 Year Change | -12.19% |
Change since IPO | -34.33% |
Recent News & Updates
Recent updates
Shareholder Returns
2F7 | DE Media | DE Market | |
---|---|---|---|
7D | 1.2% | -5.0% | 0.8% |
1Y | -2.9% | -24.3% | 6.2% |
Return vs Industry: 2F7 exceeded the German Media industry which returned -24.3% over the past year.
Return vs Market: 2F7 underperformed the German Market which returned 6.2% over the past year.
Price Volatility
2F7 volatility | |
---|---|
2F7 Average Weekly Movement | 5.1% |
Media Industry Average Movement | 5.7% |
Market Average Movement | 4.7% |
10% most volatile stocks in DE Market | 10.3% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 2F7 has not had significant price volatility in the past 3 months.
Volatility Over Time: 2F7's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1807 | 8,800 | Matt Kissner | https://www.wiley.com |
John Wiley & Sons, Inc. operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.
John Wiley & Sons, Inc. Fundamentals Summary
2F7 fundamental statistics | |
---|---|
Market cap | €1.87b |
Earnings (TTM) | -€144.68m |
Revenue (TTM) | €1.78b |
1.0x
P/S Ratio-12.9x
P/E RatioIs 2F7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2F7 income statement (TTM) | |
---|---|
Revenue | US$1.93b |
Cost of Revenue | US$574.63m |
Gross Profit | US$1.36b |
Other Expenses | US$1.51b |
Earnings | -US$157.24m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
Jun 13, 2024
Earnings per share (EPS) | -2.87 |
Gross Margin | 70.24% |
Net Profit Margin | -8.14% |
Debt/Equity Ratio | 121.3% |
How did 2F7 perform over the long term?
See historical performance and comparison